Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael V Seiden, MD, Ph.D
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Cancer Center
Tucson, Arizona, United States
- Stanford University of Obstetrics and Gynecology
Stanford, California, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Gynecologic Oncology - Hinsdale
Hinsdale, Illinois, United States
- Michiana Hematology Oncology P.C.
South Bend, Indiana, United States
- James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Magee-Women Hospital of Upmc
Pittsburgh, Pennsylvania, United States
- South Carolina Oncology Associates
Columbia, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2006
- Primary completion
- 29 Feb 2008
- Completion
- 29 Feb 2008
- Last update posted
- 19 Jul 2012
- Registered enrollment
- 47
- Registry id
- NCT00377429
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.